Skip to content

Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System

by Abbott Diabetes Care Inc

De Novo DEN250049

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA De Novo, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN250049 Date25 Aug 2026DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA Product Code
SJD
FDA applicant
Abbott Diabetes Care
Device Class
Class II
Regulation
21 CFR Part 862.1354
Advisory Committee
Clinical Chemistry
FDA Decision
DENG De Novo granted

Other devices from Abbott Diabetes Care Inc

See all devices from Abbott Diabetes Care Inc →